Evolus Inc’s (NASDAQ: EOLS) Q4 FY21 revenue increased 68% Y/Y to $34.7 million in line with interim results, surpassing consensus of $33.99 million, driven by higher volumes and average selling price.
Adjusted operating margin decreased from 64.6% to 54.3%, impacted by the higher settlement royalty rates in effect through September 2022. Non-GAAP loss from operating activities was $(12.2) million and was impacted by payment of settlement royalties. The company took out a $125 million term loan and borrowed the first tranche of $75 million. The company also has $50 million available under the second tranche of the facility to be drawn before December 31, 2022. The company reported a Q4 EPS loss of $0.33, compared to $3.28) a year ago and the consensus of $(0.19). Evolus has announced that Lauren Silvernail will retire as CFO and EVP of Corporate Development effective May 31, 2022. The search for her successor is already underway. Guidance: Evolus continues to expect total net income of $143 million – $150 million in FY22 (consensus $147.34 million), representing 43% – 50% Y/Y growth. Evolus expects an adjusted gross profit margin of 58% – 61%. Settlement royalty rates will decline significantly in September 2022, with adjusted gross profit margin expected to increase from 68% to 71% for the fourth quarter of 2022. The company remains on track to launch Nuceiva in Europe in the third quarter of 2022. to start. : EOLS shares closed 3.63% lower at $9.02 Thursday.© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
This post (EOLS) – Evolus reports smaller loss in fourth quarter, CFO retires and confirms FY22 outlook was original published at “https://www.benzinga.com/news/earnings/22/03/25985223/evolus-reports-narrower-q4-loss-cfo-retires-reaffirms-fy22-outlook”
